Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study

Roberto Bernabei; Paolo Maria Rossini; L Di Cioccio; D Gragnaniello; E Luda Di Cortemiglia; M Attar; Dario Angelo Colombo

doi:10.1159/000338228

Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study

Roberto Bernabei, Paolo Maria Rossini, L Di Cioccio, D Gragnaniello, E Luda Di Cortemiglia, M Attar, Dario Angelo Colombo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

According to experimental data, a transdermal application is preferred by caregivers of Alzheimer's disease (AD) patients compared with oral medications. The AXEPT study compared compliance to treatment among community-dwelling patients with mild-to-moderate AD treated with transdermal application compared to oral medications and caregiver satisfaction in a real clinical setting.

Lingua originale	English
pagine (da-a)	418-432
Numero di pagine	15
Rivista	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. EXTRA
Volume	2
DOI	https://doi.org/10.1159/000338228
Stato di pubblicazione	Pubblicato - 2012

Keywords

Alzheimer

Accesso al documento

10.1159/000338228

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study'. Insieme formano una fingerprint unica.

Cita questo

@article{d539479427d94a7999daefb73b62272c,

title = "Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study",

abstract = "According to experimental data, a transdermal application is preferred by caregivers of Alzheimer's disease (AD) patients compared with oral medications. The AXEPT study compared compliance to treatment among community-dwelling patients with mild-to-moderate AD treated with transdermal application compared to oral medications and caregiver satisfaction in a real clinical setting.",

keywords = "Alzheimer, Alzheimer",

author = "Roberto Bernabei and Rossini, {Paolo Maria} and {Di Cioccio}, L and D Gragnaniello and {Luda Di Cortemiglia}, E and M Attar and Colombo, {Dario Angelo}",

year = "2012",

doi = "10.1159/000338228",

language = "English",

volume = "2",

pages = "418--432",

journal = "Dementia and Geriatric Cognitive Disorders Extra",

issn = "1664-5464",

publisher = "Basel : S. Karger, 2011-",

}

Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study. / Bernabei, Roberto; Rossini, Paolo Maria; Di Cioccio, L; Gragnaniello, D; Luda Di Cortemiglia, E; Attar, M; Colombo, Dario Angelo.

In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. EXTRA, Vol. 2, 2012, pag. 418-432.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study

AU - Bernabei, Roberto

AU - Rossini, Paolo Maria

AU - Di Cioccio, L

AU - Gragnaniello, D

AU - Luda Di Cortemiglia, E

AU - Attar, M

AU - Colombo, Dario Angelo

PY - 2012

Y1 - 2012

N2 - According to experimental data, a transdermal application is preferred by caregivers of Alzheimer's disease (AD) patients compared with oral medications. The AXEPT study compared compliance to treatment among community-dwelling patients with mild-to-moderate AD treated with transdermal application compared to oral medications and caregiver satisfaction in a real clinical setting.

AB - According to experimental data, a transdermal application is preferred by caregivers of Alzheimer's disease (AD) patients compared with oral medications. The AXEPT study compared compliance to treatment among community-dwelling patients with mild-to-moderate AD treated with transdermal application compared to oral medications and caregiver satisfaction in a real clinical setting.

KW - Alzheimer

UR - http://hdl.handle.net/10807/41138

U2 - 10.1159/000338228

DO - 10.1159/000338228

M3 - Article

VL - 2

SP - 418

EP - 432

JO - Dementia and Geriatric Cognitive Disorders Extra

JF - Dementia and Geriatric Cognitive Disorders Extra

SN - 1664-5464

ER -